The race for a COVID-19 is heating up. At least two COVID-19 vaccine makers ― Pfizer and Moderna ― may have enough clinical trial data to begin seeking U.S. regulatory approval in December, according to Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases.
“Somewhere around December, you will start to see companies with enough data… so they can move forward and apply for emergency-use authority from the FDA,” he told host Dr. Howard Bauchner at a Journal of the American Medical Association webcast on Oct. 28. “Then it could be granted. It could be January, or it could be later.” Continue reading
Photo: NIAID-RML via FlickrAn electron microscope image of SARS-CoV-2 — also known as 2019-nCoV — which is the virus that causes COVID-19.
There are still many unknowns about the COVID-19 outbreak, which as of February 26, has sickened more than 81,000 people and killed more than 2,700. See this map to keep up with the figures, which are updated as new information comes in from different countries.
Key questions, such as just how contagious the virus is, how deadly it is and whether there will be widespread transmission outside of China, do not all have precise answers yet. To help answer such questions and others about prevention, the federal public health response, risk factors and similar concerns, the CDC’s COVID-19 FAQ page offers a relatively comprehensive list of questions with succinct answers and links to details. Continue reading